SCHEMBL8712424

SCHEMBL8712424

NC1CCC(N(CC(=O)O)CC(=O)O)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A12 P48065 3/20 0.32
SLC6A11 P48066 3/20 0.32
SLC6A13 Q9NSD5 3/20 0.32
TDP1 Q9NUW8 2/20 0.32
EYA2 O00167 1/20 0.32
APP P05067 1/20 0.32
ACE P12821 1/20 0.32
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
CHRM2 P08172 1/20 0.31
ADRA2A P08913 1/20 0.31
ALOX15 P16050 1/20 0.31
TSHR P16473 1/20 0.31
DRD1 P21728 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
CYP2C19 P33261 1/20 0.31
ADRA1A P35348 1/20 0.31
DRD3 P35462 1/20 0.31
BLM P54132 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL641812 0.89 TDP1 (0.39) TDP1EYA2APPACEKDM4E
SCHEMBL11186742 0.89 TDP1 (0.39) TDP1EYA2APPACEKDM4E
SCHEMBL7698248 0.84 ALDH1A1 (0.36) TDP1EYA2APPACE
SCHEMBL11186154 0.79 TDP1 (0.42) TDP1EYA2APPACEKDM4E
SCHEMBL7699086 0.79 TDP1 (0.36) SLC6A12SLC6A11SLC6A13TDP1EYA2
SCHEMBL10824154 0.79 TDP1 (0.36) TDP1EYA2APPACEKDM4E
SCHEMBL26018765 0.79 PLG (0.50) TDP1EYA2APPACELMNA
SCHEMBL17337970 0.77 ALDH1A1 (0.43) TDP1EYA2APPACEKDM4E
SCHEMBL3205284 0.77 ALDH1A1 (0.43) TDP1EYA2APPACEKDM4E
SCHEMBL16367147 0.76 HSD11B1 (0.36) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5753670-A ANTICOAGULANTS THE GREEN CROSS CORPORATION (JP) 1998-05-19 US disclosed
EP-0712844-A1 NOVEL FUSED-RING CARBOXYLIC ACID COMPOUND OR SALT THEREOF, AND MEDICINAL USE THEREOF THE GREEN CROSS CORPORATION (JP) 1996-05-22 EP disclosed